Monday, April 02, 2012 3:43:09 PM
The Company anticipates that the Form 10-K will report revenue of approximately $109.0 million for the year ended December 31, 2011, as compared to $53.2 million for the year ended December 31, 2010. The Company also anticipates reporting a net loss attributable to common stock of approximately $90.4 million, or $0.48 per share, for the year ended 2011, as compared to a net loss attributable to common stock of $296.1 million or $6.69 per share, for the comparable period of 2010
Seems like things are improving.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM